The 9th annual Medicine by Design symposium in pictures

Laura Niklason, founder, president, and chief executive officer, Humacyte Global Inc. and professor, Yale University, gives a talk titled, 'Taking fundamental innovation across the goal line'

Anna Falk, chief scientific officer, CCRM Nordic and professor, Lund University, gives a talk called, ' Using induced pluripotent stem cells to understand and heal the brain.'

Fyodor Urnov, director of technology & translation, Innovative Genomics Institute, and professor, University of California, Berkeley, gives a talk called, ‘A platform approach to CRISPR medicines on-demand for inborn errors of immunity in the pediatric population: the IGI-Danaher Beacon for CRISPR cures.’

Philip Tagari, chief scientific officer, insitro, presents a talk called, ‘Machine learning for therapeutic discovery.’

Thomas Waddell, thoracic surgeon and senior scientist, University Health Network, gives a talk called, ' Optimizing lung recellularization.'

Cristina Nostro, senior scientist, University Health Network, presents on ' Optimizing differentiation and engraftment of stem cell-derived islets for the treatment of type 1 diabetes.'

Kullervo Hynynen, vice president, research and innovation, and senior scientist, Sunnybrook Health Sciences Centre, gives a talk titled, 'From vision to reality: the journey of trans-skull focused ultrasound technology.'

Sonya MacParland, senior scientist, University Health Network, presents a talk titled, ‘Targeting resident liver immunity to treat hepatic disease.’

Trevor Reichman, surgical director, Pancreatic Transplant Program, University Health Network, gives a talk titled, ‘Update on clinical stem cell derived islet trials.’

Milica Radisic, professor, University of Toronto, gives a talk called, ‘Harnessing microfabricated systems to mature cells, vascularize tissues and unravel human disease.’

Gary Bader, professor, University of Toronto, presents on, ‘Mapping the multiscale human.’

Elmar Jaeckal, medical director, Toronto Liver Transplant Program, University Health Network, presents on, ‘Cure of type 1 diabetes by CAR-Tregs.’

Michael May, president and CEO, CCRM, and Allison Brown, executive director, Medicine by Design, discuss the launch of The CCRM Foundation, which aims to raise funds to support the translation of regenerative medicine research..

Lee Rubin, professor, Department of Stem Cell and Regenerative Biology, Harvard University, moderates a panel called, ‘Challenges and breakthroughs: Cutting-edge technologies and the future of disease recovery, prevention and care.’

Rubin (left) is joined by (left to right): David Malkin, lead, Precision Child Health, and senior staff oncologist, The Hospital for Sick Children; Marlene Rabinovitch, Dwight and Vera Dunlevie Professor of Pediatric Cardiology, Stanford University; Tagari; and Urnov.